{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:47:29Z","timestamp":1789555649894,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471974"],"award-info":[{"award-number":["81471974"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81171604"],"award-info":[{"award-number":["81171604"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.10.077","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T16:26:30Z","timestamp":1445963190000},"page":"6757-6762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice"],"prefix":"10.1016","volume":"33","author":[{"given":"Aiping","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunli","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenyi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaiyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.10.077_bib0195","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0200","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1017\/S0031182011001478","article-title":"Toxoplasma gondii: the changing paradigm of congenital toxoplasmosis","volume":"138","author":"Lindsay","year":"2011","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0205","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","article-title":"Toxoplasma gondii: from animals to humans","volume":"30","author":"Tenter","year":"2000","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0210","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1017\/S0031182012000765","article-title":"Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology","volume":"139","author":"Dubey","year":"2012","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0215","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pt.2004.07.009","article-title":"Veterinary parasitic vaccines: pitfalls and future directions","volume":"20","author":"Vercruysse","year":"2004","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0220","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1586\/erv.09.27","article-title":"Current status of toxoplasmosis vaccine development","volume":"8","author":"Kur","year":"2009","journal-title":"Expert Rev Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0225","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.pt.2010.06.004","article-title":"Immunogenetics of Toxoplasma gondii informs vaccine design","volume":"26","author":"Henriquez","year":"2010","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0230","first-page":"125","article-title":"DNA vaccines and recombinant antigens in prevention of Toxoplasma gondii infections \u2013 current status of the studies","volume":"55","author":"Hiszczy\u0144ska-Sawicka","year":"2009","journal-title":"Wiad Parazytol"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0235","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0923-2494(05)80097-5","article-title":"Role of P30 in host immunity and pathogenesis of T. gondii infection","volume":"144","author":"Kasper","year":"1993","journal-title":"Res Immunol"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0240","doi-asserted-by":"crossref","first-page":"e63201","DOI":"10.1371\/journal.pone.0063201","article-title":"Recombinant vaccines against T. gondii: comparison between homologous and heterologous vaccination protocols using two viral vectors expressing SAG1","volume":"8","author":"Mendes \u00c9A","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0245","first-page":"235","article-title":"Multiple B-cell epitopes in a recombinant GRA2 secreted antigen of Toxoplasma gondii","volume":"34","author":"Murray","year":"1993","journal-title":"Appl Parasitol"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0250","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.diagmicrobio.2007.03.003","article-title":"The dense granule protein GRA2, a new marker for the serodiagnosis of acute Toxoplasma infection: comparison of sera collected in both France and Iran from pregnant women","volume":"58","author":"Golkar","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0255","first-page":"59","article-title":"Role of secretory dense granule organelles in the pathogenesis of toxoplasmosis","volume":"219","author":"Cesbron-Delauw","year":"1996","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0260","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1017\/S0031182099004692","article-title":"In vivo expression and distribution of dense granule protein 7 (GRA7) in the exoenteric (tachyzoite, bradyzoite) and enteric (coccidian) forms of Toxoplasma gondii","volume":"119","author":"Ferguson","year":"1999","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0265","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.vetpar.2011.02.015","article-title":"IFN-\u03b3 expression and infectivity of Toxoplasma infected tissues are associated with an antibody response against GRA7 in experimentally infected pigs","volume":"179","author":"Verhelst","year":"2011","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0270","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-3024.2007.00961.x","article-title":"GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii","volume":"29","author":"Jongert","year":"2007","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0275","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/CVI.00312-10","article-title":"Protective immunity induced by Toxoplasma gondii rhoptry protein 16 against toxoplasmosis in mice","volume":"18","author":"Yuan","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0280","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1016\/j.vaccine.2011.09.099","article-title":"Immunological responses induced by a DNA vaccine expressing RON4 and by immunogenic recombinant protein RON4 failed to protect mice against chronic toxoplasmosis","volume":"29","author":"Rashid","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0285","doi-asserted-by":"crossref","first-page":"8619","DOI":"10.1016\/j.vaccine.2011.09.016","article-title":"Increased survival time in mice vaccinated with a branched lysine multiple antigenic peptide containing B- and T-cell epitopes from T. gondii antigens","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0290","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4049\/jimmunol.162.1.345","article-title":"Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms","volume":"162","author":"Jankovic","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0295","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0264-410X(00)00165-1","article-title":"Multi-epitope schistosome vaccine candidates tested for protective immunogenicity in mice","volume":"19","author":"Yang","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0300","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.vaccine.2012.01.004","article-title":"Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant","volume":"30","author":"Zhou","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0305","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4161\/hv.26703","article-title":"Toxoplasma gondii: immune response and protective efficacy induced by ROP16\/GRA7 multicomponent DNA vaccine with a genetic adjuvant B7-2","volume":"10","author":"Liu","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0310","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/icb.1997.63","article-title":"Multi-epitope DNA vaccines","volume":"75","author":"Suhrbier","year":"1997","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0315","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0264-410X(98)00236-9","article-title":"A peptide construct containing B-cell and T-cell epitopes from the foot-and-mouth disease viral VP1 protein induces efficient antiviral protection","volume":"17","author":"Volpina","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0320","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.vaccine.2004.06.003","article-title":"Differential antibody responses to Plasmodium falciparum-derived B-cell epitopes induced by diepitope multiple antigen peptides (MAP) containing different T-cell epitopes","volume":"23","author":"Vasconcelos","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0325","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.4049\/jimmunol.172.7.4575","article-title":"Multiepitope Trojan antigen peptide vaccines for the induction of antitumor CTL and Th immune responses","volume":"172","author":"Lu","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0330","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jbi.2014.11.003","article-title":"An overview of bioinformatics tools for epitope prediction: implications on vaccine development","volume":"53","author":"Soria-Guerra","year":"2015","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0335","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1016\/j.vaccine.2012.06.081","article-title":"Enhancement of protective immune responses induced by Toxoplasma gondii dense granule antigen 7 (GRA7) against toxoplasmosis in mice using a prime-boost vaccination strategy","volume":"30","author":"Min","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0340","first-page":"148","article-title":"Differentiation and functions of T cell subsets","volume":"204","author":"Mosmann","year":"1997","journal-title":"Ciba Found Symp"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0345","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4049\/jimmunol.146.1.286","article-title":"Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine","volume":"146","author":"Gazzinelli","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0350","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1016\/j.vaccine.2004.03.056","article-title":"Vaccination protects B cell-deficient mice against an oral challenge with mildly virulent Toxoplasma gondii","volume":"22","author":"Johnson","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0355","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1016\/j.vaccine.2007.01.120","article-title":"Chemical adjuvants for plasmid DNA vaccines","volume":"25","author":"Greenland","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0360","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1042\/BST20110651","article-title":"Angiogenic properties of the chemokine RANTES\/CCL5","volume":"39","author":"Suffee","year":"2011","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0365","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/eji.1830240815","article-title":"Human RANTES induces the migration of human T lymphocytes into the peripheral tissues of mice with severe combined immune deficiency","volume":"24","author":"Murphy","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0370","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/347669a0","article-title":"Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES","volume":"347","author":"Schall","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0375","doi-asserted-by":"crossref","first-page":"11173","DOI":"10.1128\/JVI.74.23.11173-11180.2000","article-title":"DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo","volume":"74","author":"Sin","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.077_bib0380","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/S0074-02762009000200019","article-title":"Vaccines against Toxoplasma gondii: challenges and opportunities","volume":"104","author":"Jongert","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T01:56:19Z","timestamp":1718157379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15015066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":38,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X15015066"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.077","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}